News About: Pharm. Affairs
The monopolistic market shaken by approval of a domestic tetravalent flu vaccine
Green Cross, a domestic vaccine manufacturer, will enter the tetravalent influenza vaccine market, which was expected to be led by GSK during this season(2015-2016).
Green Cross has started to conduct a Phase 3 clini...
Will a blockbuster-level treatment emerge in the hepatitis C treatment market?
Followed by the hepatitis B treatment market, having excellent marketability even allowing a single-substance product to record KRW 150 billion prescriptions, the hepatitis C treatment market has also been accelerated...
Did Atozet impact on sales decrease of Vytorin, resulting winning of Lipitor in the first half?
Although MSD Korea has pressured Pfizer Korea’s ‘Lipitor(generic name: atorvastatin)’ by launching ‘Atozet,’ a hyperlipidemia treatment adding ‘atorvastatin’ in ‘ezetimibe,’ this April, it was not able to make a succe...
‘Entecavir,’ a hepatitis type B treatment, became the target of priority sales for the 2nd time
A product approval for priority sales has been made for entecavir, a type B hepatitis treatment, which will be expired in substance approval on the coming October.
The Ministry of Food and Drug Safety has granted app...
Doctors quested if they would use generics of Baraclude soon expired in patent
The so-called ‘Big 5’ treatment market, expired in patent this year, has attracted the industry. Among the Big 5, the patent of Lilly’s Alimta was expired for the first time on May this year, and Pfizer’s ‘Celebrex’ a...
New FDA-proved obesity drugs, ‘Belviq’ and ‘Contrave,’ entered the domestic market
In the domestic obesity treatment market which has been depressed after expulsion of sibutramine, a series of new obesity drugs have attracted attention of the market.
While Ildong Pharmaceutical has regularized mark...
Gap among BMS, Gilead and Abbvie over hepatitis C treatments
Oral hepatitis C treatments needing no interferon are getting close to commercialization.
In the domestic market, the closest company to commercialization is BMS. The company has acquired an approval for the NS5A rep...
Led by Bayer and followed by Hyundai Pharm, the contraceptive market has been slowed down
It is known that the contraceptive market was significantly reduced last year.
According to the Ministry of Food and Drug Safety, actual output and importation of contraceptives recorded respective KRW 18.37642 billi...
Where all the graduates from 6-year college of medicine work at?
It was observed that the workplace people who graduated 6-year college of medicine was most highly positioned was pharmacies. One of the 3 graduates were observed to work in a pharmacy and hospital pharmacies were fol...
SK Chemicals’ hemophilia treatment, a biopharmaceutical new drug, is about to be approved in the U.S.
The U.S. approval procedure of the hemophilia treatment developed by a domestic pharmaceutical company has been accelerated.
SK Chemicals(President Man-hoon Park) announced on the 29th that it has completed applicati...
